株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

バイオ医薬品:世界市場の概要

Biopharmaceuticals - A Global Market Overview

発行 Industry Experts 商品コード 831993
出版日 ページ情報 英文 480 Pages, 256 Charts
即納可能
価格
本日の銀行送金レート: 1USD=109.32円で換算しております。
Back to Top
バイオ医薬品:世界市場の概要 Biopharmaceuticals - A Global Market Overview
出版日: 2019年05月01日 ページ情報: 英文 480 Pages, 256 Charts
概要

世界のバイオ医薬品市場は、2019年に2,693億米ドルへ達すると予測されています。製品別ではモノクロナール抗体が首位となり、2018年の規模は823億米ドルで33.2%のシェアを構成しており、2018年から2025年にかけては10.8%のCAGR (年間複合成長率) で成長が見込まれています。

当レポートは、世界のバイオ医薬品市場について調査分析し、世界/地域別市場の分析と見通し、主要企業などについて、体系的な情報を提供しています。

パートA:世界市場の見通し

第1章 イントロダクション

第2章 主な市場動向

第3章 世界の主要企業

  • Abbott Laboratories, Inc. (米国)
  • AbbVie Inc. (米国)
  • Amgen, Inc. (米国)
  • Astrazeneca Plc (英国)
  • Bayer AG (ドイツ)
  • Biocon Ltd. (インド)
  • Biogen Inc (米国)
  • Boehringer Ingelheim GmbH (ドイツ)
  • Bristol-Myers Squibb Company (米国)
  • Eli Lilly and Company (米国)
  • Glaxosmithkline, Plc (英国)
  • Johnson & Johnson (米国)
  • Janssen Pharmaceuticals, Inc. (米国)
  • Merck & Co., Inc. (米国)
  • Novartis AG (スイス)
  • Novo Nordisk, Inc. (米国)
  • Pfizer Inc (米国)
  • Regeneron Pharmaceuticals, Inc. (米国)
  • Roche Holding AG (スイス)
  • Genentech, Inc. (米国)
  • Sanofi (フランス)
  • Takeda Pharmaceutical Company Limited (日本)
  • Teva Pharmaceutical Industries Ltd. (イスラエル)
  • UCB S.A. (ベルギー)

第4章 主な事業・製品動向

第5章 近年のバイオ医薬品認可

第6章 世界市場の概要

  • 市場概要:製品タイプ別
    • 地域別
      • モノクロナール抗体 (moAb)
      • バイオテクワクチン
      • 組み換えヒト (RH) インスリン
      • エリスロポエチン
      • 顆粒球コロニー刺激因 (G-CSF)
      • インターフェロン
      • ヒト成長ホルモン (HGH)
      • その他のバイオ医薬品
  • 市場概要:用途別
    • 地域別
      • 自己免疫疾患
      • 糖尿病
      • 炎症・感染症
      • 神経疾患
      • 心血管疾患
      • その他の用途

パートB:地域別市場の見通し

地域別市場の概要

第7章 北米

  • 市場概要:地域別
  • 市場概要:製品タイプ別
  • 市場概要:用途別
  • 主要企業
  • 市場分析:国別
    • 米国
    • カナダ
    • メキシコ

第8章 欧州

  • 市場概要:地域別
  • 市場概要:製品タイプ別
  • 市場概要:用途別
  • 主要企業
  • 市場分析:国別
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他の欧州

第9章 アジア太平洋地域

  • 市場概要:地域別
  • 市場概要:製品タイプ別
  • 市場概要:用途別
  • 主要企業
  • 市場分析:国別
    • 日本
    • 中国
    • インド
    • 韓国
    • その他のアジア太平洋

第10章 南米

  • 市場概要:地域別
  • 市場概要:製品タイプ別
  • 市場概要:用途別
  • 市場分析:国別
    • ブラジル
    • アルゼンチン
    • その他の南米

第11章 その他の地域

  • 市場概要:製品タイプ別
  • 市場概要:用途別
  • 主要企業

パートC:産業ガイド

パートD:付録

目次
Product Code: BT001

Report Synopsis

The biopharmaceuticals market is driven by various factors, such as increase in elderly population, surge in prevalence of chronic diseases like cancer, HIV/AIDS and diabetes, and increase in adoption of biopharmaceuticals globally. Biopharmaceuticals offer several benefits including highly effective and potent action, fewer side effects, and the potential to actually cure diseases rather than merely treat the symptoms, which have significantly increased the demand for biopharmaceutical products. The market growth is attributed to the growing acceptance for biopharmaceuticals due to their ability to treat previously untreatable diseases, resulting in huge market demand for biopharmaceuticals.

Global demand for Biopharmaceuticals by product is led by Monoclonal Antibodies (moAb), estimated at US$82.3 billion (33.2% share) in 2018, and is also projected to witness the fastest CAGR of 10.8% between 2018 and 2025. The global market for biopharmaceuticals in 2019 is expected to reach US$269.3 billion.

Research Findings & Coverage

  • The Biopharmaceuticals global market explored in this study with respect to product types and application areas
  • The study extensively analyzes above mentioned product types and applications of Biopharmaceuticals in each major region/country globally for the analysis period
  • Lanadelumab Effective in Reducing Swelling Attacks in Patients with Hereditary Angioedema
  • Emerging Innovations and their Impact on Biopharma Manufacturing in the Coming Years
  • Monoclonal Antibodies Show High Potential Against Zika Virus Infection
  • Portable Bioreactor Produces Biopharmaceutical Drugs on Demand at a Point of Care
  • Key business trends focusing on product innovations/developments, M&As, JVs and other recent industry developments
  • Major companies profiled - 58
  • The industry guide includes the contact details for 843 companies

Product Outline

The report analyzes the market for the product types of Biopharmaceuticals including:

  • Monoclonal Antibodies (moAb)
  • Biotech Vaccines
  • Recombinant Human (RH) Insulin
  • Erythropoietin
  • Granulocyte Colony-Stimulating Factor (G-CSF)
  • Interferons
  • Human Growth Hormones (HGH)
  • Other Biopharmaceuticals

Application Areas of Biopharmaceuticals analyzed comprise the following:

  • Oncology
  • Autoimmune Disorders
  • Diabetes
  • Inflammatory and Infectious Diseases
  • Neurological Diseases
  • Cardiovascular Diseases
  • Others

Analysis Period, Units and Growth Rates

The report reviews, analyzes and projects the global Biopharmaceuticals market for the period 2016-2025 in terms of market value in US$ and the compound annual growth rates (CAGRs) projected from 2018 through 2025.

Geographic Coverage

  • North America (The United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Italy, Spain and Rest of Europe)
  • Asia-Pacific (Japan, China, India, South Korea and Rest of Asia-Pacific)
  • South America (Argentina, Brazil and Rest of South America)
  • Rest of World

Table of Contents

PART A: GLOBAL MARKET PERSPECTIVE

1. INTRODUCTION

  • 1.1 Product Outline
    • 1.1.1 Biopharmaceuticals
    • 1.1.2 Evolution of the Biopharmaceuticals
    • 1.1.3 Biosimilars
    • 1.1.4 Commercialization of Biopharmaceuticals
    • 1.1.5 Biopharmaceuticals Regulations
    • 1.1.6 Production of Biopharmaceuticals
      • 1.1.6.1 Microbial Cells
      • 1.1.6.2 Mammalian Cells
      • 1.1.6.3 Plant Cells
      • 1.1.6.4 Transgenics
    • 1.1.7 Disposable Manufacturing with Single-Use Systems
    • 1.1.8 Characterization of Biopharmaceuticals
      • 1.1.8.1 Circular Dichroism (CD)
      • 1.1.8.2 Capillary Electrophoresis (CE)
      • 1.1.8.3 Nuclear Magnetic Resonance (NMR)
      • 1.1.8.4 Analytical Ultracentrifugation (AUC):
      • 1.1.8.5 Differential Scanning Calorimetry (DSC)
      • 1.1.8.6 Scattering Techniques
    • 1.1.9 Delivery Systems for Biopharmaceuticals
      • 1.1.9.1 Parenteral
      • 1.1.9.2 Pulmonary Delivery
      • 1.1.9.3 Nasal Delivery
      • 1.1.9.4 Transdermal administration
      • 1.1.9.5 Oral Delivery
      • 1.1.9.6 Drug Targeting to Brain
    • 1.1.10 Categorization of Biopharmaceuticals
      • 1.1.10.1 Monoclonal Antibodies
        • 1.1.10.1.1 Production of Monoclonal Antibodies
        • 1.1.10.1.2 Primary Applications of Monoclonal Antibodies
        • 1.1.10.1.3 Therapeutic Applications of Monoclonal Antibodies
          • 1.1.10.1.3.1 Cancer
          • 1.1.10.1.3.2 Autoimmune Diseases
        • 1.1.10.1.4 Therapeutic Monoclonal Antibodies Approved by the FDA
      • 1.1.10.2 Erythropoietin (EPO)
        • 1.1.10.2.1 Functions of EPO
        • 1.1.10.2.2 Medical Uses of EPO
        • 1.1.10.2.3 Available Forms of EPO
      • 1.1.10.3 Biotech Vaccines
        • 1.1.10.3.1 Categories of Vaccines
        • 1.1.10.3.2 Recombinant Vector Vaccines
        • 1.1.10.3.3 Production of Recombinant Vector Vaccines
        • 1.1.10.3.4 Positives and Negatives of Recombinant Vector Vaccines
      • 1.1.10.4 Recombinant Human (RH) Insulin
        • 1.1.10.4.1 Production of RH Insulin
      • 1.1.10.5 Granulocyte Colony-Stimulating Factor (G-CSF)
        • 1.1.10.5.1 Biological Role of G-CSF
        • 1.1.10.5.2 Therapeutic Applications of G-CSF
        • 1.1.10.5.3 Some Highlights of G-CSF
      • 1.1.10.6 Interferons (IFNs)
        • 1.1.10.6.1 Types of Interferons
        • 1.1.10.6.2 Functions of Interferons
        • 1.1.10.6.3 Disease Therapy with Interferons
        • 1.1.10.6.4 Interferons and Drug Formulations
      • 1.1.10.7 Human Growth Hormones
        • 1.1.10.7.1 The Functioning of Human Growth Hormone
        • 1.1.10.7.2 Clinical Importance of HGH
          • 1.1.10.7.2.1 Excess of HGH
          • 1.1.10.7.2.2 Deficiency of HGH
        • 1.1.10.7.3 Use of HGH as a Medication
          • 1.1.10.7.3.1 In Replacement Therapy
          • 1.1.10.7.3.2 Additional Approved Applications
          • 1.1.10.7.3.3 Off-Label Use of GH
          • 1.1.10.7.3.4 Side Effects of GH Therapy
      • 1.1.10.8 Other Biopharmaceuticals
        • 1.1.10.8.1 Blood Factors (Factor VIII and Factor IX)
          • 1.1.10.8.1.1 Factor VIII
            • 1.1.10.8.1.1.1 Therapeutic Applications of Factor VIII
          • 1.1.10.8.1.2 Factor IX
            • 1.1.10.8.1.2.1 The Function of Factor IX in Disease
        • 1.1.10.8.2 Thrombolytic Agents (Tissue Plasminogen Activator)
          • 1.1.10.8.2.1 Function of tPA
          • 1.1.10.8.2.2 Clinical Uses of tPA
          • 1.1.10.8.2.3 Recombinant Tissue Plasminogen Activators (rtPA)
        • 1.1.10.8.3 Interleukin-Based Products
          • 1.1.10.8.3.1 Human Interleukins
        • 1.1.10.8.4 Tumor Necrosis Factor
        • 1.1.10.8.5 Therapeutic Enzymes
          • 1.1.10.8.5.1 A Few Important Therapeutic Enzymes

2. KEY MARKET TRENDS

  • 2.1 Pembrolizumab Prolongs Overall Survival in Recurrent, Metastatic Head and Neck Squamous Cell Carcinoma
  • 2.2 Lanadelumab Effective in Reducing Swelling Attacks in Patients with Hereditary Angioedema
  • 2.3 FDA and Other Federal Health Agencies to Address the Challenges in Developing New Antimicrobials
  • 2.4 Isolated Human Monoclonal Antibodies that Neutralize Norovirus
  • 2.5 Emerging Innovations and their Impact on Biopharma Manufacturing in the Coming Years
  • 2.6 Monoclonal Antibodies Show High Potential Against Zika Virus Infection
  • 2.7 Rapid Technological Advancements are Changing the Biopharmaceuticals Industry
  • 2.8 Portable Bioreactor Produces Biopharmaceutical Drugs on Demand at a Point of Care

3. KEY GLOBAL PLAYERS

  • Abbott Laboratories, Inc. (United States)
  • AbbVie Inc. (United States)
  • Amgen, Inc. (United States)
  • Astrazeneca Plc (United Kingdom)
  • Bayer AG (Germany)
  • Biocon Ltd. (India)
  • Biogen Inc (United States)
  • Boehringer Ingelheim GmbH (Germany)
  • Bristol-Myers Squibb Company (United States)
  • Eli Lilly and Company (United States)
  • Glaxosmithkline, Plc (United Kingdom)
  • Johnson & Johnson (United States)
  • Janssen Pharmaceuticals, Inc. (United States)
  • Merck & Co., Inc. (United States)
  • Novartis AG (Switzerland)
  • Novo Nordisk, Inc. (United States)
  • Pfizer Inc (United States)
  • Regeneron Pharmaceuticals, Inc. (United States)
  • Roche Holding AG (Switzerland)
  • Genentech, Inc. (United States)
  • Sanofi (France)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • UCB S.A. (Belgium)
  • 4. KEY BUSINESS AND PRODUCT TRENDS
  • Eli Lilly Acquires Loxo Oncology to expand its Oncology Portfolio
  • FDA Expands ALIMTA (Pemetrexed) Label with Combination of KEYTRUDA (Pembrolizumab) and Platinum Chemotherapy for the First-Line NSCLC Treatment
  • GlaxoSmithKline (GSK) Acquires TESARO, a Biopharmaceutical Company for $5.1 Billion
  • FDA Approves Adacel (Tdap) Vaccine for Repeat Vaccinations
  • Sanofi to Enter into License Agreement with Biomunex to Develop Antibody Therapeutics
  • AbSci and Sanofi to Enter into Manufacturing Partnership
  • Takeda Completes Acquisition of Shire Plc
  • 19 December 2018Biogen Collaborates With C4 Therapeutics to Develop Treatments for Neurological Conditions
  • Abbvie to Collaborate With Tizona to Develop Antibody Immunotherapy
  • Bristol-Myers Squibb to Acquire Celgene for $74-Billion
  • FDA Approved Sprycel® (Dasatinib) Tablets in Combination with Chemotherapy in Certain Pediatric Patients
  • Novartis to Acquires Endocyte, a US-based biopharmaceutical company for $2.1 Billion
  • Abbvie Submits NDA to FDA and MAA to EMA for Upadacitinib
  • GSK and Pfizer to Merge Consumer Healthcare Businesses to Form a Joint Venture
  • Lilly Signs Research Collaboration and License Agreement with Aduro Biotech
  • Lilly to Acquire Hydra's Pre-Clinical Pain Program TRPA1
  • Roche Subsidiary Genentech to Acquire NASH-Focused Jecure Therapeutics
  • Pfizer Gains Global Patent License for AbbVie's HUMIRA® (Adalimumab)
  • Amgen and Provention Bio Enters Into Co-Development Agreement
  • Astrazeneca to Sell Synagis US Rights to Sobi for $1.5 Billion
  • Lilly Partners with NextCure to Develop Immuno-Oncology Medicines
  • AstraZeneca's MedImmune Expands Innate Pharma Oncology Collaboration
  • Abbvie Teams Up With Morphic Therapeutic For Fibrotic Disease Treatments
  • Roche to Acquire Immuno-Oncology Company Tusk Therapeutics
  • Janssen Partners With Arrowhead to Treat Hepatitis B
  • Merck to collaborate with Dragonfly Therapeutics on Solid-Tumor Immunotherapies
  • Sanofi to Enter Research Collaboration with Dyadic
  • Pfizer Teams Up With BioNTech to Develop mRNA -Based Flu Vaccines for Prevention of Influenza
  • Amgen to Build Next-Generation Biomanufacturing Plant Rhode Island
  • Takeda Pharmaceutical to Acquire TiGenix, a Biopharmaceutical Company
  • GSK Signs R&D Partnership with 23andme
  • Novartis Inks $1.1 Billion Monoclonal Antibody Deal With MorphoSys and Galapagos
  • Novartis Partners With CELLforCURE to Manufacture CAR-T Therapies
  • Abbvie and Calico Collaborated to Develop T-Cell Therapies for Cancer
  • Sanofi to Partner with Translate Bio $850 Million mRNA Vaccine Development Deal
  • Sanofi to Acquire Ablynx in $4.8 Billion Deal
  • Alexion Teams Up With Complement to Treat Neurodegenerative Disorders
  • WuXi Biologics to Invest $60 Million in US Plant
  • FDA Approval for Samsung BioLogics's mab Drug Substance Manufacturing Plant
  • Novartis to Acquire AveXis, Gene-Therapy Biotech Company for $8.7 Billion
  • Lilly to Buy ARMO Biosciences
  • Janssen Biotech to Acquire BeneVir Biopharm
  • Merck to Expand mRNA Cancer Vaccines Collaboration with Moderna
  • Janssen to Collaborate With Bristol-Myers Squibb to Develop Factor XIa (FXIa) Inhibitors
  • Alexion to Buy Sweden-Based Wilson Therapeutics
  • Lilly to Partner with Sigilon to Develop Encapsulated Cell Therapies
  • Boehringer Ingelheim Inks $1.7 Billion Immuno-Oncology Deal With OSE Immunotherapeutics
  • Pfizer to Enter Asset Contribution Agreement with Allogene Therapeutics
  • Sanofi to Acquire Biogen's Bioverativ, a Hemophilia-focused company
  • AstraZeneca's MedImmune to Spins off Biotech Company Focused on Autoimmune Diseases
  • Abbvie to Sign Strategic Collaboration with Alector Partner on Alzheimer's Disease Immunotherapies
  • Lilly and CureVac Inks $1.8 Billion Deal to Develop mRNA Cancer Vaccines
  • J&J Terminates Two Drugs Sirukumab and Talacotuzumab from Pipeline
  • J&J's Stelara Received FDA Approval for Expanded Indication
  • AbbVie and BMS Partners on clinical research collaboration
  • J&J to Enter R&D Partnership with Health and Human Services (HHS)

5. RECENT BIOPHARMACEUTICALS APPROVALS

6. GLOBAL MARKET OVERVIEW

  • 6.1 Global Biopharmaceuticals Market Overview by Product Type
    • 6.1.1 Global Biopharmaceuticals Product Market Overview by Geographic Region
      • 6.1.1.1 Monoclonal Antibodies (moAb)
      • 6.1.1.2 Biotech Vaccines
      • 6.1.1.3 Recombinant Human (RH) Insulin
      • 6.1.1.4 Erythropoietin
      • 6.1.1.5 Granulocyte Colony-Stimulating Factor (G-CSF)
      • 6.1.1.6 Interferons
      • 6.1.1.7 Human Growth Hormones (HGH)
      • 6.1.1.8 Other Biopharmaceuticals
  • 6.2 Global Biopharmaceuticals Market Overview by Application
    • 6.2.1 Global Biopharmaceuticals Application Market Overview by Geographic Region
      • 6.2.1.1 Oncology
      • 6.2.1.2 Autoimmune Disorders
      • 6.2.1.3 Diabetes
      • 6.2.1.4 Inflammatory and Infectious Diseases
      • 6.2.1.5 Neurological Diseases
      • 6.2.1.6 Cardiovascular Diseases
      • 6.2.1.7 Other Applications

PART B: REGIONAL MARKET PERSPECTIVE

REGIONAL MARKET OVERVIEW

7. NORTH AMERICA

  • 7.1 North American Biopharmaceuticals Market Overview by Geographic Region
  • 7.2 North American Biopharmaceuticals Market Overview by Product Type
    • 7.2.1 Biopharmaceuticals Product Segment Market Overview by NA Region
      • 7.2.1.1 Monoclonal Antibodies (moAb)
      • 7.2.1.2 Biotech Vaccines
      • 7.2.1.3 Recombinant Human (RH) Insulin
      • 7.2.1.4 Erythropoietin
      • 7.2.1.5 Granulocyte Colony-Stimulating Factor (G-CSF)
      • 7.2.1.6 Interferons
      • 7.2.1.7 Human Growth Hormones (HGH)
      • 7.2.1.8 Other Biopharmaceuticals
  • 7.3 North American Biopharmaceuticals Market Overview by Application
    • 7.3.1 Biopharmaceuticals Application Market Overview by NA Region
      • 7.3.1.1 Oncology
      • 7.3.1.2 Autoimmune Disorders
      • 7.3.1.3 Diabetes
      • 7.3.1.4 Inflammatory and Infectious Diseases
      • 7.3.1.5 Neurological Diseases
      • 7.3.1.6 Cardiovascular Diseases
      • 7.3.1.7 Other Applications
  • 7.4 Major Market Players
    • Abbott Laboratories, Inc. (United States)
    • AbbVie Inc. (United States)
    • Alder Biopharmaceuticals Inc. (United States)
    • Alexion Pharmaceuticals, Inc (United States)
    • Amgen, Inc. (United States)
    • Analytical Biological Services Inc (United States)
    • Array Biopharma Inc. (United States)
    • Atlanta Biologicals, Inc (United States)
    • Biogen Inc (United States)
    • Bristol-Myers Squibb Company (United States)
    • Charles River Laboratories International, Inc. (United States)
    • Eli Lilly and Company (United States)
    • Fujifilm Diosynth Biotechnologies USA Inc (United States)
    • Genentech, Inc. (United States)
    • Johnson & Johnson (United States)
    • Janssen Pharmaceuticals, Inc. (United States)
    • Merck & Co., Inc. (United States)
    • Millennium Pharmaceuticals, Inc. (United States)
    • Novo Nordisk, Inc. (United States)
    • Pfizer Inc (United States)
    • Regeneron Pharmaceuticals, Inc. (United States)
    • Sanofi-Aventis U.S. LLC (United States)
    • Seattle Genetics, Inc (United States)
    • Soligenix, Inc. (United States)
    • Sunovion Pharmaceuticals Inc. (United States)
  • 7.5 Country-wise Analysis of North American Biopharmaceuticals Market
    • 7.5.1 The United States
      • 7.5.1.1 United States Biopharmaceuticals Market Overview by Product Type
      • 7.5.1.2 United States Biopharmaceuticals Market Overview by Application
    • 7.5.2 Canada
      • 7.5.2.1 Canadian Biopharmaceuticals Market Overview by Product Type
      • 7.5.2.2 Canadian Biopharmaceuticals Market Overview by Application
    • 7.5.3 Mexico
      • 7.5.3.1 Mexican Biopharmaceuticals Market Overview by Product Type
      • 7.5.3.2 Mexican Biopharmaceuticals Market Overview by Application

8. EUROPE

  • 8.1 European Biopharmaceuticals Market Overview by Geographic Region
  • 8.2 European Biopharmaceuticals Market Overview by Product Type
    • 8.2.1 Biopharmaceuticals Product Segment Market Overview by EU Region
      • 8.2.1.1 Monoclonal Antibodies (moAb)
      • 8.2.1.2 Biotech Vaccines
      • 8.2.1.3 Recombinant Human (RH) Insulin
      • 8.2.1.4 Erythropoietin
      • 8.2.1.5 Granulocyte Colony-Stimulating Factor (G-CSF)
      • 8.2.1.6 Interferons
      • 8.2.1.7 Human Growth Hormones (HGH)
      • 8.2.1.8 Other Biopharmaceuticals
  • 8.3 European Biopharmaceuticals Market Overview by Application
    • 8.3.1 Biopharmaceuticals Application Market Overview by EU Region
      • 8.3.1.1 Oncology
      • 8.3.1.2 Autoimmune Disorders
      • 8.3.1.3 Diabetes
      • 8.3.1.4 Inflammatory and Infectious Diseases
      • 8.3.1.5 Neurological Diseases
      • 8.3.1.6 Cardiovascular Diseases
      • 8.3.1.7 Other Applications
  • 8.4 Major Market Players
    • 3P Biopharmaceuticals S.L. (Spain)
    • Applikon Biotechnology B.V. (The Netherlands)
    • Albumedix Ltd. (United Kingdom)
    • Astrazeneca Plc (United Kingdom)
    • Bayer AG (Germany)
    • Boehringer Ingelheim GmbH (Germany)
    • Cellgenix GmbH (Germany)
    • Evotec AG (Germany)
    • Glaxosmithkline, Plc (United Kingdom)
    • Novartis AG (Switzerland)
    • Roche Holding AG (Switzerland)
    • Sanofi (France)
    • UCB S.A. (Belgium)
  • 8.5 Country-wise Analysis of European Biopharmaceuticals Market
    • 8.5.1 Germany
      • 8.5.1.1 German Biopharmaceuticals Market Overview by Product Type
      • 8.5.1.2 German Biopharmaceuticals Market Overview by Application
    • 8.5.2 France
      • 8.5.2.1 French Biopharmaceuticals Market Overview by Product Type
      • 8.5.2.2 French Biopharmaceuticals Market Overview by Application
    • 8.5.3 The United Kingdom
      • 8.5.3.1 United Kingdom Biopharmaceuticals Market Overview by Product Type
      • 8.5.3.2 United Kingdom Biopharmaceuticals Market Overview by Application
    • 8.5.4 Italy
      • 8.5.4.1 Italy Biopharmaceuticals Market Overview by Product Type
      • 8.5.4.2 Italy Biopharmaceuticals Market Overview by Application
    • 8.5.5 Spain
      • 8.5.5.1 Spanish Biopharmaceuticals Market Overview by Product Type
      • 8.5.5.2 Spanish Biopharmaceuticals Market Overview by Application
    • 8.5.6 Rest of Europe
      • 8.5.6.1 Rest of Europe Biopharmaceuticals Market Overview by Product Type
      • 8.5.6.2 Rest of Europe Biopharmaceuticals Market Overview by Application

9. ASIA-PACIFIC

  • 9.1 Asia-Pacific Biopharmaceuticals Market Overview by Geographic Region
  • 9.2 Asia-Pacific Biopharmaceuticals Market Overview by Product Type
    • 9.2.1 Biopharmaceuticals Product Segment Market Overview by Asia-Pacific Region
      • 9.2.1.1 Monoclonal Antibodies (moAb)
      • 9.2.1.2 Biotech Vaccines
      • 9.2.1.3 Recombinant Human (RH) Insulin
      • 9.2.1.4 Erythropoietin
      • 9.2.1.5 Granulocyte Colony-Stimulating Factor (G-CSF)
      • 9.2.1.6 Interferons
      • 9.2.1.7 Human Growth Hormones (HGH)
      • 9.2.1.8 Other Biopharmaceuticals
  • 9.3 Asia-Pacific Biopharmaceuticals Market Overview by Application
    • 9.3.1 Biopharmaceuticals Application Market Overview by Asia-Pacific Region
      • 9.3.1.1 Oncology
      • 9.3.1.2 Autoimmune Disorders
      • 9.3.1.3 Diabetes
      • 9.3.1.4 Inflammatory and Infectious Diseases
      • 9.3.1.5 Neurological Diseases
      • 9.3.1.6 Cardiovascular Diseases
      • 9.3.1.7 Other Biopharmaceutical Applications
  • 9.4 Major Market Players
    • Beijing SL Pharmaceutical Co Ltd (China)
    • Beijing Tiantan Biological Products Co Ltd (China)
    • Biocon Ltd. (India)
    • Biological E Limited (India)
    • Cadila Healthcare Limited (Zydus Cadila) (India)
    • Celltrion, Inc. (South Korea)
    • Glenmark Pharmaceuticals Limited (India)
    • GVK Biosciences Pvt Ltd (India)
    • Hualan Biological Engineering Inc (China)
    • Reliance Life Sciences Pvt Ltd (India)
    • RPG Life Sciences Limited (India)
    • Samsung Biologics Co Ltd (South Korea)
    • Shanghai Institute of Biological Products (China)
    • Shantha Biotechnics Ltd (India)
    • Sun Pharmaceutical Industries Ltd (India)
    • Suven Life Sciences Ltd (India)
    • Takeda Pharmaceutical Company Limited (Japan)
    • Torrent Pharmaceuticals Limited (India)
  • 9.5 Country-wise Analysis of Asia-Pacific Biopharmaceuticals Market
    • 9.5.1 Japan
      • 9.5.1.1 Japanese Biopharmaceuticals Market Overview by Product Type
      • 9.5.1.2 Japanese Biopharmaceuticals Market Overview by Application
    • 9.5.2 China
      • 9.5.2.1 Chinese Biopharmaceuticals Market Overview by Product Type
      • 9.5.2.2 Chinese Biopharmaceuticals Market Overview by Application
    • 9.5.3 India
      • 9.5.3.1 Indian Biopharmaceuticals Market Overview by Product Type
      • 9.5.3.2 Indian Biopharmaceuticals Market Overview by Application
    • 9.5.4 South Korea
      • 9.5.4.1 South Korean Biopharmaceuticals Market Overview by Product Type
      • 9.5.4.2 South Korean Biopharmaceuticals Market Overview by Application
    • 9.5.5 Rest of Asia-Pacific
      • 9.5.5.1 Rest of Asia-Pacific Biopharmaceuticals Market Overview by Product Type
      • 9.5.5.2 Rest of Asia-Pacific Biopharmaceuticals Market Overview by Application

10. SOUTH AMERICA

  • 10.1 South American Biopharmaceuticals Market Overview by Geographic Region
  • 10.2 South American Biopharmaceuticals Market Overview by Product Type
    • 10.2.1 Biopharmaceuticals Product Segment Market Overview by SA Region
      • 10.2.1.1 Monoclonal Antibodies (moAb)
      • 10.2.1.2 Biotech Vaccines
      • 10.2.1.3 Recombinant Human (RH) Insulin
      • 10.2.1.4 Erythropoietin
      • 10.2.1.5 Granulocyte Colony-Stimulating Factor (G-CSF)
      • 10.2.1.6 Interferons
      • 10.2.1.7 Human Growth Hormones (HGH)
      • 10.2.1.8 Other Biopharmaceuticals
  • 10.3 South American Biopharmaceuticals Market Overview by Application
    • 10.3.1 Biopharmaceuticals Application Market Overview by SA Region
      • 10.3.1.1 Oncology
      • 10.3.1.2 Autoimmune Disorders
      • 10.3.1.3 Diabetes
      • 10.3.1.4 Inflammatory and Infectious Diseases
      • 10.3.1.5 Neurological Diseases
      • 10.3.1.6 Cardiovascular Diseases
      • 10.3.1.7 Other Applications
  • 10.4 Country-wise Analysis of South American Biopharmaceuticals Market
    • 10.4.1 Brazil
      • 10.4.1.1 Brazilian Biopharmaceuticals Market Overview by Product Type
      • 10.4.1.2 Brazilian Biopharmaceuticals Market Overview by Application
    • 10.4.2 Argentina
      • 10.4.2.1 Argentinean Biopharmaceuticals Market Overview by Product Type
      • 10.4.2.2 Argentinean Biopharmaceuticals Market Overview by Application
    • 10.4.3 Rest of South America
      • 10.4.3.1 Rest of South America Biopharmaceuticals Market Overview by Product Type
      • 10.4.3.2 Rest of South America Biopharmaceuticals Market Overview by Application

11. REST OF WORLD

  • 11.1 Rest of World Biopharmaceuticals Market Overview by Product Type
  • 11.2 Rest of World Biopharmaceuticals Market Overview by Application
  • 11.3 Major Market Players
    • Teva Pharmaceutical Industries Ltd. (Israel)
    • UNV Medicine Ltd. (Israel)

PART C: GUIDE TO THE INDUSTRY

  • 1. NORTH AMERICA
  • 2. EUROPE
  • 3. ASIA-PACIFIC
  • 4. REST OF WORLD

PART D: ANNEXURE

  • 1. RESEARCH METHODOLOGY
  • 2. FEEDBACK

Charts & Graphs

PART A: GLOBAL MARKET PERSPECTIVE

  • Chart 1: Global Biopharmaceuticals Market (2018 & 2025) by Geographic Region
  • Chart 2: Global Biopharmaceuticals Market (2018 & 2025) by Product
  • Chart 3: Global Biopharmaceuticals Market (2018 & 2025) by Application
  • Chart 4: Global Biopharmaceuticals Market Analysis (2016-2025) in USD Million
  • Chart 5: Global Biopharmaceuticals Market Analysis (2016-2025) by Product - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
  • Chart 6: Glance at 2016, 2019 and 2025 Global Biopharmaceuticals Market Share (%) by Product - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 7: Global Monoclonal Antibodies (moAb) Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 8: Glance at 2016, 2019 and 2025 Global Monoclonal Antibodies (moAb) Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 9: Global Biotech Vaccines Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 10: Glance at 2016, 2019 and 2025 Global Biotech Vaccines Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 11: Global Recombinant Human (RH) Insulin Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 12: Glance at 2016, 2019 and 2025 Global Recombinant Human (RH) Insulin Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 13: Global Erythropoietin Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 14: Glance at 2016, 2019 and 2025 Global Erythropoietin Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 15: Global Granulocyte Colony-Stimulating Factor (G-CSF) Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 16: Glance at 2016, 2019 and 2025 Global Granulocyte Colony-Stimulating Factor (G-CSF) Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 17: Global Interferons Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 18: Glance at 2016, 2019 and 2025 Global Interferons Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 19: Global Human Growth Hormones (HGH) Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 20: Glance at 2016, 2019 and 2025 Global Human Growth Hormones (HGH) Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 21: Global Other Biopharmaceuticals Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 22: Glance at 2016, 2019 and 2025 Global Other Biopharmaceuticals Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 23: Global Biopharmaceuticals Market Analysis (2016-2025) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
  • Chart 24: Glance at 2016, 2019 and 2025 Global Biopharmaceuticals Market Share (%) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others
  • Chart 25: Global Biopharmaceuticals in Oncology Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 26: Glance at 2016, 2019 and 2025 Global Biopharmaceuticals in Oncology Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 27: Global Biopharmaceuticals in Autoimmune Disorders Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 28: Glance at 2016, 2019 and 2025 Global Biopharmaceuticals in Autoimmune Disorders Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 29: Global Biopharmaceuticals in Diabetes Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 30: Glance at 2016, 2019 and 2025 Global Biopharmaceuticals in Diabetes Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 31: Global Biopharmaceuticals in Inflammatory and Infectious Diseases Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 32: Glance at 2016, 2019 and 2025 Global Biopharmaceuticals in Inflammatory and Infectious Diseases Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 33: Global Biopharmaceuticals in Neurological Diseases Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 34: Glance at 2016, 2019 and 2025 Global Biopharmaceuticals in Neurological Diseases Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 35: Global Biopharmaceuticals in Cardiovascular Diseases Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 36: Glance at 2016, 2019 and 2025 Global Biopharmaceuticals in Cardiovascular Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 37: Global Biopharmaceuticals in Other Applications Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 38: Glance at 2016, 2019 and 2025 Global Biopharmaceuticals in Other Applications Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World

PART B: REGIONAL MARKET PERSPECTIVE

  • Chart 39: Global Biopharmaceuticals Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 40: Glance at 2016, 2019 and 2025 Global Biopharmaceuticals Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World

REGIONAL MARKET OVERVIEW

NORTH AMERICA

  • Chart 41: North American Biopharmaceuticals Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 42: Glance at 2016, 2019 and 2025 North American Biopharmaceuticals Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 43: North American Biopharmaceuticals Market Analysis (2016-2025) by Product - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
  • Chart 44: Glance at 2016, 2019 and 2025 North American Biopharmaceuticals Market Share (%) by Product - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 45: North American Monoclonal Antibodies (moAb) Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 46: Glance at 2016, 2019 and 2025 North American Monoclonal Antibodies (moAb) Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 47: North American Biotech Vaccines Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 48: Glance at 2016, 2019 and 2025 North American Biotech Vaccines Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 49: North American Recombinant Human (RH) Insulin Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 50: Glance at 2016, 2019 and 2025 North American Recombinant Human (RH) Insulin Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 51: North American Erythropoietin Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 52: Glance at 2016, 2019 and 2025 North American Erythropoietin Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 53: North American Granulocyte Colony-Stimulating Factor (G-CSF) Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 54: Glance at 2016, 2019 and 2025 North American Granulocyte Colony-Stimulating Factor (G-CSF) Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 55: North American Interferons Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 56: Glance at 2016, 2019 and 2025 North American Interferons Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 57: North American Human Growth Hormones (HGH) Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 58: Glance at 2016, 2019 and 2025 North American Human Growth Hormones (HGH) Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 59: North American Other Biopharmaceuticals Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 60: Glance at 2016, 2019 and 2025 North American Other Biopharmaceuticals Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 61: North American Biopharmaceuticals Market Analysis (2016-2025) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
  • Chart 62: Glance at 2016, 2019 and 2025 North American Biopharmaceuticals Market Share (%) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others
  • Chart 63: North American Biopharmaceuticals in Oncology Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 64: Glance at 2016, 2019 and 2025 North American Biopharmaceuticals in Oncology Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 65: North American Biopharmaceuticals in Autoimmune Disorders Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 66: Glance at 2016, 2019 and 2025 North American Biopharmaceuticals in Autoimmune Disorders Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 67: North American Biopharmaceuticals in Diabetes Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 68: Glance at 2016, 2019 and 2025 North American Biopharmaceuticals in Diabetes Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 69: North American Biopharmaceuticals in Inflammatory and Infectious Diseases Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 70: Glance at 2016, 2019 and 2025 North American Biopharmaceuticals in Inflammatory and Infectious Diseases Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 71: North American Biopharmaceuticals in Neurological Diseases Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 72: Glance at 2016, 2019 and 2025 North American Biopharmaceuticals in Neurological Diseases Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 73: North American Biopharmaceuticals in Cardiovascular Diseases Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 74: Glance at 2016, 2019 and 2025 North American Biopharmaceuticals in Cardiovascular Diseases Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 75: North American Biopharmaceuticals in Other Applications Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 76: Glance at 2016, 2019 and 2025 North American Biopharmaceuticals in Other Applications Market Share (%) by Geographic Region - United States, Canada and Mexico

The United States

  • Chart 77: United States Biopharmaceuticals Market Analysis (2016-2025) by Product Segment - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
  • Chart 78: Glance at 2016, 2019 and 2025 United States Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 79: United States Biopharmaceuticals Market Analysis (2016-2025) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
  • Chart 80: Glance at 2016, 2019 and 2025 United States Biopharmaceuticals Market Share (%) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

Canada

  • Chart 81: Canadian Biopharmaceuticals Market Analysis (2016-2025) by Product Segment - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
  • Chart 82: Glance at 2016, 2019 and 2025 Canadian Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 83: Canadian Biopharmaceuticals Market Analysis (2016-2025) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
  • Chart 84: Glance at 2016, 2019 and 2025 Canadian Biopharmaceuticals Market Share (%) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

Mexico

  • Chart 85: Mexican Biopharmaceuticals Market Analysis (2016-2025) by Product Segment - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
  • Chart 86: Glance at 2016, 2019 and 2025 Mexican Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 87: Mexican Biopharmaceuticals Market Analysis (2016-2025) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
  • Chart 88: Glance at 2016, 2019 and 2025 Mexican Biopharmaceuticals Market Share (%) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

EUROPE

  • Chart 89: European Biopharmaceuticals Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 90: Glance at 2016, 2019 and 2025 European Biopharmaceuticals Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 91: European Biopharmaceuticals Market Analysis (2016-2025) by Product - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
  • Chart 92: Glance at 2016, 2019 and 2025 European Biopharmaceuticals Market Share (%) by Product - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 93: European Monoclonal Antibodies (moAb) Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 94: Glance at 2016, 2019 and 2025 European Monoclonal Antibodies (moAb) Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 95: European Biotech Vaccines Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 96: Glance at 2016, 2019 and 2025 European Biotech Vaccines Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 97: European Recombinant Human (RH) Insulin Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 98: Glance at 2016, 2019 and 2025 European Recombinant Human (RH) Insulin Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 99: European Erythropoietin Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 100: Glance at 2016, 2019 and 2025 European Erythropoietin Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 101: European Granulocyte Colony-Stimulating Factor (G-CSF) Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 102: Glance at 2016, 2019 and 2025 European Granulocyte Colony-Stimulating Factor (G-CSF) Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 103: European Interferons Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 104: Glance at 2016, 2019 and 2025 European Interferons Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 105: European Human Growth Hormones (HGH) Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 106: Glance at 2016, 2019 and 2025 European Human Growth Hormones (HGH) Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 107: European Other Biopharmaceuticals Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 108: Glance at 2016, 2019 and 2025 European Other Biopharmaceuticals Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 109: European Biopharmaceuticals Market Analysis (2016-2025) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
  • Chart 110: Glance at 2016, 2019 and 2025 European Biopharmaceuticals Market Share (%) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others
  • Chart 111: European Biopharmaceuticals in Oncology Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 112: Glance at 2016, 2019 and 2025 European Biopharmaceuticals in Oncology Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 113: European Biopharmaceuticals in Autoimmune Disorders Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 114: Glance at 2016, 2019 and 2025 European Biopharmaceuticals in Autoimmune Disorders Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 115: European Biopharmaceuticals in Diabetes Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 116: Glance at 2016, 2019 and 2025 European Biopharmaceuticals in Diabetes Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 117: European Biopharmaceuticals in Inflammatory and Infectious Diseases Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 118: Glance at 2016, 2019 and 2025 European Biopharmaceuticals in Inflammatory and Infectious Diseases Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 119: European Biopharmaceuticals in Neurological Diseases Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 120: Glance at 2016, 2019 and 2025 European Biopharmaceuticals in Neurological Diseases Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 121: European Biopharmaceuticals in Cardiovascular Diseases Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 122: Glance at 2016, 2019 and 2025 European Biopharmaceuticals in Cardiovascular Diseases Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 123: European Biopharmaceuticals in Other Applications Market Analysis (2016-2025) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
  • Chart 124: Glance at 2016, 2019 and 2025 European Biopharmaceuticals in Other Applications Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe

Germany

  • Chart 125: German Biopharmaceuticals Market Analysis (2016-2025) by Product - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
  • Chart 126: Glance at 2016, 2019 and 2025 German Biopharmaceuticals Market Share (%) by Product - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 127: German Biopharmaceuticals Market Analysis (2016-2025) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
  • Chart 128: Glance at 2016, 2019 and 2025 German Biopharmaceuticals Market Share (%) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

France

  • Chart 129: French Biopharmaceuticals Market Analysis (2016-2025) by Product - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
  • Chart 130: Glance at 2016, 2019 and 2025 French Biopharmaceuticals Market Share (%) by Product - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 131: French Biopharmaceuticals Market Analysis (2016-2025) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
  • Chart 132: Glance at 2016, 2019 and 2025 French Biopharmaceuticals Market Share (%) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

The United Kingdom

  • Chart 133: United Kingdom Biopharmaceuticals Market Analysis (2016-2025) by Product - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
  • Chart 134: Glance at 2016, 2019 and 2025 United Kingdom Biopharmaceuticals Market Share (%) by Product - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 135: United Kingdom Biopharmaceuticals Market Analysis (2016-2025) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
  • Chart 136: Glance at 2016, 2019 and 2025 United Kingdom Biopharmaceuticals Market Share (%) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

Italy

  • Chart 137: Italian Biopharmaceuticals Market Analysis (2016-2025) by Product - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
  • Chart 138: Glance at 2016, 2019 and 2025 Italian Biopharmaceuticals Market Share (%) by Product - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 139: Italian Biopharmaceuticals Market Analysis (2016-2025) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
  • Chart 140: Glance at 2016, 2019 and 2025 Italian Biopharmaceuticals Market Share (%) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

Spain

  • Chart 141: Spanish Biopharmaceuticals Market Analysis (2016-2025) by Product - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
  • Chart 142: Glance at 2016, 2019 and 2025 Spanish Biopharmaceuticals Market Share (%) by Product - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 143: Spanish Biopharmaceuticals Market Analysis (2016-2025) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
  • Chart 144: Glance at 2016, 2019 and 2025 Spanish Biopharmaceuticals Market Share (%) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

Rest of Europe

  • Chart 145: Rest of Europe Biopharmaceuticals Market Analysis (2016-2025) by Product - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
  • Chart 146: Glance at 2016, 2019 and 2025 Rest of Europe Biopharmaceuticals Market Share (%) by Product - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 147: Rest of Europe Biopharmaceuticals Market Analysis (2016-2025) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
  • Chart 148: Glance at 2016, 2019 and 2025 Rest of Europe Biopharmaceuticals Market Share (%) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

ASIA-PACIFIC

  • Chart 149: Asia-Pacific Biopharmaceuticals Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 150: Glance at 2016, 2019 and 2025 Asia-Pacific Biopharmaceuticals Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
  • Chart 151: Asia-Pacific Biopharmaceuticals Market Analysis (2016-2025) by Product - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
  • Chart 152: Glance at 2016, 2019 and 2025 Asia-Pacific Biopharmaceuticals Market Share (%) by Product - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 153: Asia-Pacific Monoclonal Antibodies (moAb) Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 154: Glance at 2016, 2019 and 2025 Asia-Pacific Monoclonal Antibodies (moAb) Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
  • Chart 155: Asia-Pacific Biotech Vaccines Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 156: Glance at 2016, 2019 and 2025 Asia-Pacific Biotech Vaccines Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
  • Chart 157: Asia-Pacific Recombinant Human (RH) Insulin Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 158: Glance at 2016, 2019 and 2025 Asia-Pacific Recombinant Human (RH) Insulin Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
  • Chart 159: Asia-Pacific Erythropoietin Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 160: Glance at 2016, 2019 and 2025 Asia-Pacific Erythropoietin Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
  • Chart 161: Asia-Pacific Granulocyte Colony-Stimulating Factor (G-CSF) Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 162: Glance at 2016, 2019 and 2025 Asia-Pacific Granulocyte Colony-Stimulating Factor (G-CSF) Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
  • Chart 163: Asia-Pacific Interferons Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 164: Glance at 2016, 2019 and 2025 Asia-Pacific Interferons Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
  • Chart 165: Asia-Pacific Human Growth Hormones (HGH) Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 166: Glance at 2016, 2019 and 2025 Asia-Pacific Human Growth Hormones (HGH) Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
  • Chart 167: Asia-Pacific Other Biopharmaceuticals Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 168: Glance at 2016, 2019 and 2025 Asia-Pacific Other Biopharmaceuticals Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
  • Chart 169: Asia-Pacific Biopharmaceuticals Market Analysis (2016-2025) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
  • Chart 170: Glance at 2016, 2019 and 2025 Asia-Pacific Biopharmaceuticals Market Share (%) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others
  • Chart 171: Glance at 2016, 2019 and 2025 Asia-Pacific Biopharmaceuticals in Oncology Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
  • Chart 172: Asia-Pacific Biopharmaceuticals in Oncology Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 173: Asia-Pacific Biopharmaceuticals in Autoimmune Disorders Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 174: Glance at 2016, 2019 and 2025 Asia-Pacific Biopharmaceuticals in Autoimmune Disorders Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
  • Chart 175: Asia-Pacific Biopharmaceuticals in Diabetes Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 176: Glance at 2016, 2019 and 2025 Asia-Pacific Biopharmaceuticals in Diabetes Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
  • Chart 177: Asia-Pacific Biopharmaceuticals in Inflammatory and Infectious Diseases Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 178: Glance at 2016, 2019 and 2025 Asia-Pacific Biopharmaceuticals in Inflammatory and Infectious Diseases Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
  • Chart 179: Asia-Pacific Biopharmaceuticals in Neurological Diseases Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 180: Glance at 2016, 2019 and 2025 Asia-Pacific Biopharmaceuticals in Neurological Diseases Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
  • Chart 181: Asia-Pacific Biopharmaceuticals in Cardiovascular Diseases Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 182: Glance at 2016, 2019 and 2025 Asia-Pacific Biopharmaceuticals in Cardiovascular Diseases Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
  • Chart 183: Asia-Pacific Biopharmaceuticals in Other Applications Market Analysis (2016-2025) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 184: Glance at 2016, 2019 and 2025 Asia-Pacific Biopharmaceuticals in Other Applications Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific

Japan

  • Chart 185: Japanese Biopharmaceuticals Market Analysis (2016-2025) by Product - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
  • Chart 186: Glance at 2016, 2019 and 2025 Japanese Biopharmaceuticals Market Share (%) by Product - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 187: Japanese Biopharmaceuticals Market Analysis (2016-2025) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
  • Chart 188: Glance at 2016, 2019 and 2025 Japanese Biopharmaceuticals Market Share (%) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

China

  • Chart 189: Chinese Biopharmaceuticals Market Analysis (2016-2025) by Product - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
  • Chart 190: Glance at 2016, 2019 and 2025 Chinese Biopharmaceuticals Market Share (%) by Product - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 191: Chinese Biopharmaceuticals Market Analysis (2016-2025) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
  • Chart 192: Glance at 2016, 2019 and 2025 Chinese Biopharmaceuticals Market Share (%) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

India

  • Chart 193: Indian Biopharmaceuticals Market Analysis (2016-2025) by Product - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
  • Chart 194: Glance at 2016, 2019 and 2025 Indian Biopharmaceuticals Market Share (%) by Product - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 195: Indian Biopharmaceuticals Market Analysis (2016-2025) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
  • Chart 196: Glance at 2016, 2019 and 2025 Indian Biopharmaceuticals Market Share (%) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

South Korea

  • Chart 197: South Korean Biopharmaceuticals Market Analysis (2016-2025) by Product - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
  • Chart 198: Glance at 2016, 2019 and 2025 South Korean Biopharmaceuticals Market Share (%) by Product - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 199: South Korean Biopharmaceuticals Market Analysis (2016-2025) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
  • Chart 200: Glance at 2016, 2019 and 2025 South Korean Biopharmaceuticals Market Share (%) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

Rest of Asia-Pacific

  • Chart 201: Rest of Asia-Pacific Biopharmaceuticals Market Analysis (2016-2025) by Product - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
  • Chart 202: Glance at 2016, 2019 and 2025 Rest of Asia-Pacific Biopharmaceuticals Market Share (%) by Product - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 203: Rest of Asia-Pacific Biopharmaceuticals Market Analysis (2016-2025) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
  • Chart 204: Glance at 2016, 2019 and 2025 Rest of Asia-Pacific Biopharmaceuticals Market Share (%) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

SOUTH AMERICA

  • Chart 205: South American Biopharmaceuticals Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
  • Chart 206: Glance at 2016, 2019 and 2025 South American Biopharmaceuticals Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
  • Chart 207: South American Biopharmaceuticals Market Analysis (2016-2025) by Product - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
  • Chart 208: Glance at 2016, 2019 and 2025 South American Biopharmaceuticals Market Share (%) by Product - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 209: South American Monoclonal Antibodies (moAb) Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
  • Chart 210: Glance at 2016, 2019 and 2025 South American Monoclonal Antibodies (moAb) Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
  • Chart 211: South American Biotech Vaccines Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
  • Chart 212: Glance at 2016, 2019 and 2025 South American Biotech Vaccines Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
  • Chart 213: South American Recombinant Human (RH) Insulin Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
  • Chart 214: Glance at 2016, 2019 and 2025 South American Recombinant Human (RH) Insulin Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
  • Chart 215: South American Erythropoietin Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
  • Chart 216: Glance at 2016, 2019 and 2025 South American Erythropoietin Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
  • Chart 217: South American Granulocyte Colony-Stimulating Factor (G-CSF) Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
  • Chart 218: Glance at 2016, 2019 and 2025 South American Granulocyte Colony-Stimulating Factor (G-CSF) Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
  • Chart 219: South American Interferons Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
  • Chart 220: Glance at 2016, 2019 and 2025 South American Interferons Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
  • Chart 221: South American Human Growth Hormones (HGH) Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
  • Chart 222: Glance at 2016, 2019 and 2025 South American Human Growth Hormones (HGH) Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
  • Chart 223: South American Other Biopharmaceuticals Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
  • Chart 224: Glance at 2016, 2019 and 2025 South American Other Biopharmaceuticals Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
  • Chart 225: South American Biopharmaceuticals Market Analysis (2016-2025) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
  • Chart 226: Glance at 2016, 2019 and 2025 South American Biopharmaceuticals Market Share (%) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others
  • Chart 227: South American Biopharmaceuticals in Oncology Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
  • Chart 228: Glance at 2016, 2019 and 2025 South American Biopharmaceuticals in Oncology Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
  • Chart 229: South American Biopharmaceuticals in Autoimmune Disorders Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
  • Chart 230: Glance at 2016, 2019 and 2025 South American Biopharmaceuticals in Autoimmune Disorders Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
  • Chart 231: South American Biopharmaceuticals in Diabetes Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
  • Chart 232: Glance at 2016, 2019 and 2025 South American Biopharmaceuticals in Diabetes Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
  • Chart 233: South American Biopharmaceuticals in Inflammatory and Infectious Diseases Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
  • Chart 234: Glance at 2016, 2019 and 2025 South American Biopharmaceuticals in Inflammatory and Infectious Diseases Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
  • Chart 235: South American Biopharmaceuticals in Neurological Diseases Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
  • Chart 236: Glance at 2016, 2019 and 2025 South American Biopharmaceuticals in Neurological Diseases Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
  • Chart 237: South American Biopharmaceuticals in Cardiovascular Diseases Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
  • Chart 238: Glance at 2016, 2019 and 2025 South American Biopharmaceuticals in Cardiovascular Diseases Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America
  • Chart 239: South American Biopharmaceuticals in Other Applications Market Analysis (2016-2025) by Geographic Region - Brazil, Argentina and Rest of South America in USD Million
  • Chart 240: Glance at 2016, 2019 and 2025 South American Biopharmaceuticals in Other Applications Market Share (%) by Geographic Region - Brazil, Argentina and Rest of South America

Brazil

  • Chart 241: Brazilian Biopharmaceuticals Market Analysis (2016-2025) by Product - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
  • Chart 242: Glance at 2016, 2019 and 2025 Brazilian Biopharmaceuticals Market Share (%) by Product - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 243: Brazilian Biopharmaceuticals Market Analysis (2016-2025) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
  • Chart 244: Glance at 2016, 2019 and 2025 Brazilian Biopharmaceuticals Market Share (%) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

Argentina

  • Chart 245: Argentinean Biopharmaceuticals Market Analysis (2016-2025) by Product - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
  • Chart 246: Glance at 2016, 2019 and 2025 Argentinean Biopharmaceuticals Market Share (%) by Product - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 247: Argentinean Biopharmaceuticals Market Analysis (2016-2025) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
  • Chart 248: Glance at 2016, 2019 and 2025 Argentinean Biopharmaceuticals Market Share (%) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

Rest of South America

  • Chart 249: Rest of South America Biopharmaceuticals Market Analysis (2016-2025) by Product - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
  • Chart 250: Glance at 2016, 2019 and 2025 Rest of South America Biopharmaceuticals Market Share (%) by Product - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 251: Rest of South America Biopharmaceuticals Market Analysis (2016-2025) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
  • Chart 252: Glance at 2016, 2019 and 2025 Rest of South America Biopharmaceuticals Market Share (%) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

REST OF WORLD

  • Chart 253: Rest of World Biopharmaceuticals Market Analysis (2016-2025) by Product - Monoclonal Antibodies (moAb), Biotech Vaccines, Recombinant Human (RH) Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in USD Million
  • Chart 254: Glance at 2016, 2019 and 2025 Rest of World Biopharmaceuticals Market Share (%) by Product - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 255: Rest of World Biopharmaceuticals Market Analysis (2016-2025) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others in USD Million
  • Chart 256: Glance at 2016, 2019 and 2025 Rest of World Biopharmaceuticals Market Share (%) by Application - Oncology, Autoimmune Disorders, Diabetes, Inflammatory and Infectious Diseases, Neurological Diseases, Cardiovascular Diseases and Others

Tables:

  • Table 1: Anti-Inflammatory Monoclonal Antibodies
  • Table 2: Anti-Cancer Monoclonal Antibodies
  • Table 3: Other Monoclonal Antibodies
  • Table 4: Monoclonal Antibodies Approved by FDA
  • Table 5: Different Forms of Erythropoietin (EPO)
  • Table 6: Different Types of Human Interleukins
  • Table 7: Worldwide Approvals of Biopharmaceuticals through 2017 to 2019
Back to Top